TIVICAY DISPERSIBLE TABLET 5 MG
Product details
Registration number: SIN16504P
Classification: Prescription Only
Active ingredients: Dolutegravir Sodium eqv Dolutegravir
Strength: 5.00 mg
Dosage form: TABLET, FOR SUSPENSION
Route: ORAL
Registrant: GLAXOSMITHKLINE PTE LTD
ATC code: J05AX12
HSA approval date: 30 May 2022
Manufacturer(s):
- Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations)
- Glaxo Wellcome, S.A. (Primary packager and Secondary packager)
Manufacturing country/countries: SPAIN; UNITED KINGDOM
What are the HSA registration number and classification for TIVICAY DISPERSIBLE TABLET 5 MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16504P
Classification: Prescription Only
What active ingredients and strength are recorded for TIVICAY DISPERSIBLE TABLET 5 MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Dolutegravir Sodium eqv Dolutegravir
Strength: 5.00 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for TIVICAY DISPERSIBLE TABLET 5 MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FOR SUSPENSION
Route: ORAL
Who is the recorded registrant for TIVICAY DISPERSIBLE TABLET 5 MG?
According to the HSA dataset updated 7 August 2026:
Registrant: GLAXOSMITHKLINE PTE LTD
Which manufacturers and countries are listed for TIVICAY DISPERSIBLE TABLET 5 MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations)
- Glaxo Wellcome, S.A. (Primary packager and Secondary packager)
Manufacturing country/countries: SPAIN; UNITED KINGDOM
Where can I look up TIVICAY DISPERSIBLE TABLET 5 MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16504P or the exact product name TIVICAY DISPERSIBLE TABLET 5 MG. The general register link does not preselect this product.
What are the source dates for this TIVICAY DISPERSIBLE TABLET 5 MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this TIVICAY DISPERSIBLE TABLET 5 MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16504P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)